DHTRF.US DRI Healthcare Trust

Healthcare Pharmaceuticals USA Stocks
13.47 USD
Close of Nov 13, 2026
10.71 13.72
Market cap
USD 740M
P/E
12.7x
P/B
1.59x
ROE
12.7%
Dividend yield
2.90%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 4 quarters up to Sep 2026.

Is DHTRF.US undervalued?

Graham number
Price13.47
Graham value14.21
Discount5.2%

DHTRF.US trades 5.2% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

DRI Healthcare Trust fundamental analysis

No fundamental analysis for DRI Healthcare Trust yet.

DRI Healthcare Trust stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About DRI Healthcare Trust

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

Full company profile